Patents by Inventor Barry John Allen

Barry John Allen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PAI-2 conjugates for the treatment and imaging of cancer
    Patent number: 7998934
    Abstract: A method is described for detecting, visualizing, or treating cells, particularly cancerous cells, that express a uPA/uPAR complex. The method employs a PAI-2 conjugate molecule that comprises PAI-2 or a functional derivative, homologue, analogue, chemical equivalent or mimetic thereof, which PAI-2 is bound, linked, or otherwise associated with a toxin or label.
    Type: Grant
    Filed: October 14, 2008
    Date of Patent: August 16, 2011
    Assignees: PAI-2 Pty Limited, University of Wollongong, Medical Scitec Australia Pty Ltd.
    Inventors: Marie Ranson, Barry John Allen, Clive Leighton Bunn
  • Method For Treating Cancer
    Publication number: 20090311174
    Abstract: The present invention relates to methods, kits, compositions and uses thereof for treating cancer. In particular, the present invention relates to methods, kits, compositions and uses thereof for the treatment of metastatic cancer, the treatment of angiogenesis associated with metastatic cancer, inhibiting formation of vasculature associated with metastatic cancer, killing pericytes associated with metastatic cancer and killing cancer cells contiguous with tumour capillaries associated with metastatic cancer, comprising a killing agent conjugated to a protein, and wherein said killing agent conjugated to said protein binds to at least one cell associated with the metastatic cancer.
    Type: Application
    Filed: July 21, 2006
    Publication date: December 17, 2009
    Inventor: Barry John Allen
  • PAI-2 conjugates for the treatment and imaging of cancer
    Patent number: 7547441
    Abstract: A method is described for detecting, visualizing, or treating cells, particularly cancerous cells, that express a uPA/uPAR complex. The method employs a PAI-2 conjugate molecule that comprises PAI-2 or a functional derivative, homologue, analogue, chemical equivalent or mimetic thereof, which PAI-2 is bound, linked, or otherwise associated with a toxin or label.
    Type: Grant
    Filed: February 23, 2001
    Date of Patent: June 16, 2009
    Assignees: PAI-2 Pty Limited, University of Wollongong, Medical Scitec Australia Pty Ltd
    Inventors: Marie Ranson, Barry John Allen, Clive Leighton Bunn
  • PAI-2 conjugates for the treatment and imaging of cancer
    Publication number: 20090136421
    Abstract: A method is described for detecting, visualizing, or treating cells, particularly cancerous cells, that express a uPA/uPAR complex. The method employs a PAI-2 conjugate molecule that comprises PAI-2 or a functional derivative, homologue, analogue, chemical equivalent or mimetic thereof, which PAI-2 is bound, linked, or otherwise associated with a toxin or label.
    Type: Application
    Filed: October 14, 2008
    Publication date: May 28, 2009
    Inventors: Marie Ranson, Barry John Allen, Clive Leighton Bunn
  • PAI-2 conjugates for the treatment and imaging of cancer
    Publication number: 20020002134
    Abstract: A method is described for detecting, visualizing, or treating cells, particularly cancerous cells, that express a uPA/uPAR complex. The method employs a PAI-2 conjugate molecule that comprises PAI-2 or a functional derivative, homologue, analogue, chemical equivalent or mimetic thereof, which PAI-2 is bound, linked, or otherwise associated with a toxin or label.
    Type: Application
    Filed: February 23, 2001
    Publication date: January 3, 2002
    Inventors: Marie Ranson, Barry John Allen, Clive Leighton Bunn